|
|
|
|
|
Last Trade
|
Last Trade:
$19.56
|
Change:
0.24 (1.24%)
|
Trade Time:
04:00 PM EST
|
Market Cap:
$1.62B
|
|
|
|
|
|
|
Description of Business
|
|
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell
immunotherapy company that is developing novel treatments for patients with
cancer, autoimmune and viral diseases. We have several T-cell immunotherapies in
clinical development and are progressing a next-generation allogeneic chimeric
antigen receptor T-cell, or CAR T program.
|
|
|
|